BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yanaoka K, Oka M, Mukoubayashi C, Yoshimura N, Enomoto S, Iguchi M, Magari H, Utsunomiya H, Tamai H, Arii K. Cancer high-risk subjects identified by serum pepsinogen tests: outcomes after 10-year follow-up in asymptomatic middle-aged males. Cancer Epidemiol Biomarkers Prev. 2008;17:838-845. [PMID: 18398025 DOI: 10.1158/1055-9965.epi-07-2762] [Cited by in Crossref: 71] [Cited by in F6Publishing: 38] [Article Influence: 5.1] [Reference Citation Analysis]
Number Citing Articles
1 Gantuya B, Oyuntsetseg K, Bolor D, Erdene-Ochir Y, Sanduijav R, Davaadorj D, Tserentogtokh T, Uchida T, Yamaoka Y. Evaluation of serum markers for gastric cancer and its precursor diseases among high incidence and mortality rate of gastric cancer area. Gastric Cancer. 2019;22:104-112. [PMID: 29934751 DOI: 10.1007/s10120-018-0844-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
2 Leja M, You W, Camargo MC, Saito H. Implementation of gastric cancer screening - the global experience. Best Pract Res Clin Gastroenterol. 2014;28:1093-1106. [PMID: 25439074 DOI: 10.1016/j.bpg.2014.09.005] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 3.5] [Reference Citation Analysis]
3 Enomoto S, Maekita T, Ohata H, Yanaoka K, Oka M, Ichinose M. Novel risk markers for gastric cancer screening: Present status and future prospects. World J Gastrointest Endosc 2010; 2(12): 381-387 [PMID: 21191511 DOI: 10.4253/wjge.v2.i12.381] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
4 Ichikawa H, Sugimoto M, Sakao Y, Sahara S, Ohashi N, Kato A, Sugimoto K, Furuta T, Andoh A, Sakao T, Yasuda H. Relationship between ghrelin, Helicobacter pylori and gastric mucosal atrophy in hemodialysis patients. World J Gastroenterol 2016; 22(47): 10440-10449 [PMID: 28058025 DOI: 10.3748/wjg.v22.i47.10440] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
5 Hishida A, Matsuo K, Goto Y, Naito M, Wakai K, Tajima K, Hamajima N. No associations of Toll-like receptor 2 (TLR2) -196 to -174del polymorphism with the risk of Helicobacter pylori seropositivity, gastric atrophy, and gastric cancer in Japanese. Gastric Cancer. 2010;13:251-257. [PMID: 21128061 DOI: 10.1007/s10120-010-0567-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
6 Calanzani N, Druce PE, Snudden C, Milley KM, Boscott R, Behiyat D, Saji S, Martinez-Gutierrez J, Oberoi J, Funston G, Messenger M, Emery J, Walter FM. Identifying Novel Biomarkers Ready for Evaluation in Low-Prevalence Populations for the Early Detection of Upper Gastrointestinal Cancers: A Systematic Review. Adv Ther 2021;38:793-834. [PMID: 33306189 DOI: 10.1007/s12325-020-01571-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Bang CS, Lee JJ, Baik GH. Prediction of Chronic Atrophic Gastritis and Gastric Neoplasms by Serum Pepsinogen Assay: A Systematic Review and Meta-Analysis of Diagnostic Test Accuracy. J Clin Med 2019;8:E657. [PMID: 31083485 DOI: 10.3390/jcm8050657] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
8 Iijima K, Koike T, Abe Y, Yamagishi H, Ara N, Asanuma K, Uno K, Imatani A, Nakaya N, Ohara S. Gastric hyposecretion in esophageal squamous-cell carcinomas. Dig Dis Sci. 2010;55:1349-1355. [PMID: 19513836 DOI: 10.1007/s10620-009-0853-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
9 Yoshida T, Kato J, Maekita T, Yamashita S, Enomoto S, Ando T, Niwa T, Deguchi H, Ueda K, Inoue I. Altered mucosal DNA methylation in parallel with highly active Helicobacter pylori-related gastritis. Gastric Cancer. 2013;16:488-497. [PMID: 23292007 DOI: 10.1007/s10120-012-0230-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
10 Mun YG, Choi MG, Lim CH, Lee HH, Kang DH, Park JM, Song KY. Factors Affecting Endoscopic Curative Resection of Gastric Cancer in the Population-Based Screening Era. Clin Endosc 2018;51:478-84. [PMID: 29852731 DOI: 10.5946/ce.2018.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Kalniņa Z, Meistere I, Kikuste I, Tolmanis I, Zayakin P, Linē A. Emerging blood-based biomarkers for detection of gastric cancer. World J Gastroenterol 2015; 21(41): 11636-11653 [PMID: 26556992 DOI: 10.3748/wjg.v21.i41.11636] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 25] [Article Influence: 4.6] [Reference Citation Analysis]
12 Dinis-Ribeiro M, Areia M, de Vries AC, Marcos-Pinto R, Monteiro-Soares M, O'Connor A, Pereira C, Pimentel-Nunes P, Correia R, Ensari A, Dumonceau JM, Machado JC, Macedo G, Malfertheiner P, Matysiak-Budnik T, Megraud F, Miki K, O'Morain C, Peek RM, Ponchon T, Ristimaki A, Rembacken B, Carneiro F, Kuipers EJ; European Society of Gastrointestinal Endoscopy., European Helicobacter Study Group., European Society of Pathology., Sociedade Portuguesa de Endoscopia Digestiva. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy 2012;44:74-94. [PMID: 22198778 DOI: 10.1055/s-0031-1291491] [Cited by in Crossref: 389] [Cited by in F6Publishing: 344] [Article Influence: 35.4] [Reference Citation Analysis]
13 Yoon H, Kim N. Diagnosis and management of high risk group for gastric cancer. Gut Liver. 2015;9:5-17. [PMID: 25547086 DOI: 10.5009/gnl14118] [Cited by in Crossref: 121] [Cited by in F6Publishing: 106] [Article Influence: 17.3] [Reference Citation Analysis]
14 Park YH, Kim N. Review of atrophic gastritis and intestinal metaplasia as a premalignant lesion of gastric cancer. J Cancer Prev. 2015;20:25-40. [PMID: 25853101 DOI: 10.15430/jcp.2015.20.1.25] [Cited by in Crossref: 124] [Cited by in F6Publishing: 68] [Article Influence: 17.7] [Reference Citation Analysis]
15 Baek SM, Kim N, Kwon YJ, Lee HS, Kim HY, Lee J, Yoon H, Shin CM, Park YS, Lee DH. Role of Serum Pepsinogen II and Helicobacter pylori Status in the Detection of Diffuse-Type Early Gastric Cancer in Young Individuals in South Korea. Gut Liver 2020;14:439-49. [PMID: 31533397 DOI: 10.5009/gnl19091] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
16 Yeh JM, Hur C, Ward Z, Schrag D, Goldie SJ. Gastric adenocarcinoma screening and prevention in the era of new biomarker and endoscopic technologies: a cost-effectiveness analysis. Gut. 2016;65:563-574. [PMID: 25779597 DOI: 10.1136/gutjnl-2014-308588] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 7.3] [Reference Citation Analysis]
17 Inoue I, Kato J, Yoshimura N, Maeda Y, Moribata K, Shingaki N, Deguchi H, Enomoto S, Maekita T, Ueda K, Iguchi M, Tamai H, Fujishiro M, Yamamichi N, Takeshita T, Ichinose M. Elevated risk of recurrent colorectal neoplasia with Helicobacter pylori-associated chronic atrophic gastritis: A follow-up study of patients with endoscopically resected colorectal neoplasia. Mol Clin Oncol. 2013;1:75-82. [PMID: 24649126 DOI: 10.3892/mco.2012.22] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
18 Bornschein J, Selgrad M, Wex T, Kuester D, Malfertheiner P. Serological assessment of gastric mucosal atrophy in gastric cancer. BMC Gastroenterol. 2012;12:10. [PMID: 22289789 DOI: 10.1186/1471-230x-12-10] [Cited by in Crossref: 47] [Cited by in F6Publishing: 27] [Article Influence: 4.7] [Reference Citation Analysis]
19 Zhang QY, Lv Z, Sun LP, Dong NN, Xing CZ, Yuan Y. Clinical significance of serum markers reflecting gastric function and H. pylori infection in colorectal cancer. J Cancer 2019;10:2229-36. [PMID: 31258726 DOI: 10.7150/jca.27134] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
20 Pasechnikov V, Chukov S, Fedorov E, Kikuste I, Leja M. Gastric cancer: Prevention, screening and early diagnosis. World J Gastroenterol 2014; 20(38): 13842-13862 [PMID: 25320521 DOI: 10.3748/wjg.v20.i38.13842] [Cited by in CrossRef: 153] [Cited by in F6Publishing: 145] [Article Influence: 19.1] [Reference Citation Analysis]
21 Scott I, Umair S, Savoian MS, Simpson HV. Abomasal dysfunction and cellular and mucin changes during infection of sheep with larval or adult Teladorsagia circumcincta. PLoS One 2017;12:e0186752. [PMID: 29073245 DOI: 10.1371/journal.pone.0186752] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
22 Yang L, Ying X, Liu S, Lyu G, Xu Z, Zhang X, Li H, Li Q, Wang N, Ji J. Gastric cancer: Epidemiology, risk factors and prevention strategies. Chin J Cancer Res. 2020;32:695-704. [PMID: 33446993 DOI: 10.21147/j.issn.1000-9604.2020.06.03] [Cited by in Crossref: 3] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
23 Hamashima C. Current issues and future perspectives of gastric cancer screening. World J Gastroenterol 2014; 20(38): 13767-13774 [PMID: 25320514 DOI: 10.3748/wjg.v20.i38.13767] [Cited by in CrossRef: 95] [Cited by in F6Publishing: 95] [Article Influence: 11.9] [Reference Citation Analysis]
24 De Re V, Orzes E, Canzonieri V, Maiero S, Fornasarig M, Alessandrini L, Cervo S, Steffan A, Zanette G, Mazzon C, De Paoli P, Cannizzaro R. Pepsinogens to Distinguish Patients With Gastric Intestinal Metaplasia and Helicobacter pylori Infection Among Populations at Risk for Gastric Cancer. Clin Transl Gastroenterol 2016;7:e183. [PMID: 27441820 DOI: 10.1038/ctg.2016.42] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
25 Laiyemo AO, Kamangar F, Marcus PM, Taylor PR, Virtamo J, Albanes D, Stolzenberg-Solomon RZ. Atrophic gastritis and the risk of incident colorectal cancer. Cancer Causes Control 2010;21:163-70. [PMID: 19838812 DOI: 10.1007/s10552-009-9446-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
26 Siregar GA, Parwati I, Achmad TH, Syukriani YF. Association between VEGF-634G>C Gene Polymorphism with Gastric Premalignant Lesions and Serum VEGF Levels in Helicobacter pylori Gastritis Patients. Open Access Maced J Med Sci 2018;6:1328-34. [PMID: 30159051 DOI: 10.3889/oamjms.2018.266] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
27 Leja M, Park JY, Murillo R, Liepniece-Karele I, Isajevs S, Kikuste I, Rudzite D, Krike P, Parshutin S, Polaka I, Kirsners A, Santare D, Folkmanis V, Daugule I, Plummer M, Herrero R. Multicentric randomised study of Helicobacter pylori eradication and pepsinogen testing for prevention of gastric cancer mortality: the GISTAR study. BMJ Open 2017;7:e016999. [PMID: 28801429 DOI: 10.1136/bmjopen-2017-016999] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
28 Nakata H, Enomoto S, Maekita T, Inoue I, Ueda K, Deguchi H, Shingaki N, Moribata K, Maeda Y, Mori Y, Iguchi M, Tamai H, Yamamichi N, Fujishiro M, Kato J, Ichinose M. Transnasal and standard transoral endoscopies in the screening of gastric mucosal neoplasias. World J Gastrointest Endosc 2011; 3(8): 162-170 [PMID: 21954413 DOI: 10.4253/wjge.v3.i8.162] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
29 Kishikawa H, Kimura K, Takarabe S, Kaida S, Nishida J. Helicobacter pylori Antibody Titer and Gastric Cancer Screening. Dis Markers 2015;2015:156719. [PMID: 26494936 DOI: 10.1155/2015/156719] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
30 Inoue I, Kato J, Tamai H, Iguchi M, Maekita T, Yoshimura N, Ichinose M. Helicobacter pylori-related chronic gastritis as a risk factor for colonic neoplasms. World J Gastroenterol 2014; 20(6): 1485-1492 [PMID: 24587623 DOI: 10.3748/wjg.v20.i6.1485] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
31 Kim GH, Bang SJ, Ende AR, Hwang JH. Is screening and surveillance for early detection of gastric cancer needed in Korean Americans? Korean J Intern Med 2015;30:747-58. [PMID: 26552450 DOI: 10.3904/kjim.2015.30.6.747] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
32 Miki K. Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels - "ABC method". Proc Jpn Acad Ser B Phys Biol Sci 2011;87:405-14. [PMID: 21785258 DOI: 10.2183/pjab.87.405] [Cited by in Crossref: 123] [Cited by in F6Publishing: 120] [Article Influence: 12.3] [Reference Citation Analysis]
33 Hishida A, Matsuo K, Goto Y, Naito M, Wakai K, Tajima K, Hamajima N. Associations of a PTPN11 G/A polymorphism at intron 3 with Helicobactor pylori seropositivity, gastric atrophy and gastric cancer in Japanese. BMC Gastroenterol 2009;9:51. [PMID: 19589142 DOI: 10.1186/1471-230X-9-51] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
34 Re V, Zorzi M, Caggiari L, Repetto O, Brisotto G, Magris R, Zanussi S, Steffan A, Cannizzaro R. Polymorphisms in Pepsinogen C and miRNA Genes Associate with High Serum Pepsinogen II in Gastric Cancer Patients. Microorganisms 2021;9:126. [PMID: 33430456 DOI: 10.3390/microorganisms9010126] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
35 Han XL, Yi CL, Ma JD, He Y, Wu LM, Wang YF, Yang HJ, Liang DY, Shi JF. Clinical Value of Pepsinogen in the Screening, Prevention, and Diagnosis of Gastric Cancer. Lab Med 2021:lmab035. [PMID: 34508270 DOI: 10.1093/labmed/lmab035] [Reference Citation Analysis]
36 Matsuo Y, Kido Y, Akada J, Shiota S, Binh TT, Trang TTH, Dung HDQ, Tung PH, Tri TD, Thuan NPM, Tam LQ, Nam BC, Khien VV, Yamaoka Y. Novel CagA ELISA exhibits enhanced sensitivity of Helicobacter pylori CagA antibody. World J Gastroenterol 2017; 23(1): 48-59 [PMID: 28104980 DOI: 10.3748/wjg.v23.i1.48] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
37 Chen MY, Gong YH, Yuan Y. Differential distribution of the PPIase gene in Helicobacter pylori strains isolated from patients with different gastric diseases. Shijie Huaren Xiaohua Zazhi 2012; 20(2): 155-159 [DOI: 10.11569/wcjd.v20.i2.155] [Reference Citation Analysis]
38 Lin JY, Huang ZS, Deng YB. Meta-analysis on validity of serum pepsinogen measurement for mass screening of gastric carcinoma in the high-risk population. Shijie Huaren Xiaohua Zazhi 2014; 22(22): 3300-3306 [DOI: 10.11569/wcjd.v22.i22.3300] [Reference Citation Analysis]
39 Lee SY. Endoscopic gastritis, serum pepsinogen assay, and Helicobacter pylori infection. Korean J Intern Med. 2016;31:835-844. [PMID: 27604795 DOI: 10.3904/kjim.2016.166] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 4.5] [Reference Citation Analysis]